{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:14:54Z","timestamp":1790615694643,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR001880"],"award-info":[{"award-number":["TL1TR001880"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uplifting Athletes\/Lymphangiomatosis and Gorham's Disease Alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41431-022-01123-9","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T02:02:46Z","timestamp":1653357766000},"page":"1022-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomaly"],"prefix":"10.1038","volume":"30","author":[{"given":"Mandi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Biko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-6727","authenticated-orcid":false,"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Skraban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-893X","authenticated-orcid":false,"given":"Elaine H.","family":"Zackai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Dori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-8123","authenticated-orcid":false,"given":"Sarah E.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"1123_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCRESAHA.121.318142","volume":"129","author":"T Makinen","year":"2021","unstructured":"Makinen T, Boon LM, Vikkula M, Alitalo K. Lymphatic malformations: genetics, mechanisms and therapeutic strategies. Circ Res. 2021;129:136\u201354.","journal-title":"Circ Res"},{"key":"1123_CR2","doi-asserted-by":"publisher","unstructured":"Ricci KW, Iacobas I. How we approach the diagnosis and management of complex lymphatic anomalies. Pediatr Blood Cancer. 2021;e28985. https:\/\/doi.org\/10.1002\/pbc.28985.","DOI":"10.1002\/pbc.28985"},{"key":"1123_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1024\/0301-1526\/a000414","volume":"44","author":"RK Clemens","year":"2015","unstructured":"Clemens RK, Pfammatter T, Meier TO, Alomari AI, Amann-Vesti BR. Combined and complex vascular malformations. Vasa. 2015;44:92\u2013105.","journal-title":"Vasa."},{"key":"1123_CR4","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136:e203\u201314.","journal-title":"Pediatrics."},{"key":"1123_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1148\/radiol.14132616","volume":"273","author":"Y Dori","year":"2014","unstructured":"Dori Y, Zviman MM, Itkin M. Dynamic contrast-enhanced MR lymphangiography: feasibility study in swine. Radiology. 2014;273:410\u20136.","journal-title":"Radiology."},{"key":"1123_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.tvir.2016.10.002","volume":"19","author":"Y Dori","year":"2016","unstructured":"Dori Y. Novel lymphatic imaging techniques. Tech Vasc Interventional Radiol. 2016;19:255\u201361.","journal-title":"Tech Vasc Interventional Radiol."},{"key":"1123_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00247-018-04337-6","volume":"49","author":"DM Biko","year":"2019","unstructured":"Biko DM, Reisen B, Otero HJ, Ravishankar C, Victoria T, Glatz AC, et al. Imaging of central lymphatic abnormalities in Noonan syndrome. Pediatric Radiol. 2019;49:586\u201392.","journal-title":"Pediatric Radiol"},{"key":"1123_CR8","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/jmri.27542","volume":"53","author":"M Mills","year":"2021","unstructured":"Mills M, van Zanten M, Borri M, Mortimer PS, Gordon K, Ostergaard P, et al. Systematic review of magnetic resonance lymphangiography from a technical perspective. J Magn Reson Imaging. 2021;53:1766\u201390.","journal-title":"J Magn Reson Imaging."},{"key":"1123_CR9","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/hmg\/ddy218","volume":"27","author":"D Li","year":"2018","unstructured":"Li D, Wenger TL, Seiler C, March ME, Gutierrez-Uzquiza A, Kao C, et al. Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly. Hum Mol Genet. 2018;27:3233\u201345.","journal-title":"Hum Mol Genet"},{"key":"1123_CR10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41591-019-0479-2","volume":"25","author":"D Li","year":"2019","unstructured":"Li D, March ME, Gutierrez-Uzquiza A, Kao C, Seiler C, Pinto E, et al. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Nat Med. 2019;25:1116\u201322.","journal-title":"Nat Med"},{"key":"1123_CR11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/cge.13915","volume":"99","author":"D Li","year":"2021","unstructured":"Li D, Sheppard SE, Peroutka C, Barnes C, Reid JR, Smith CL, et al. Expanded phenotypic spectrum of JAG1-associated diseases: Central conducting lymphatic anomaly with a pathogenic variant in JAG1. Clin Genet. 2021;99:742\u20133.","journal-title":"Clin Genet"},{"key":"1123_CR12","doi-asserted-by":"publisher","first-page":"e20200167","DOI":"10.1542\/peds.2020-0167","volume":"146","author":"Y Dori","year":"2020","unstructured":"Dori Y, Smith C, Pinto E, Snyder K, March ME, Hakonarson H, et al. Severe lymphatic disorder resolved with MEK inhibition in a patient with Noonan syndrome and SOS1 mutation. Pediatrics 2020;146:e20200167.","journal-title":"Pediatrics"},{"key":"1123_CR13","doi-asserted-by":"publisher","first-page":"eabm4869","DOI":"10.1126\/scitranslmed.abm4869","volume":"14","author":"AB Byrne","year":"2022","unstructured":"Byrne AB, Brouillard P, Sutton DL, Kazenwadel J, Montazaribarforoushi S, Secker GA, et al. Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema. Sci Transl Med. 2022;14:eabm4869.","journal-title":"Sci Transl Med"},{"key":"1123_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ejhg.2015.175","volume":"24","author":"S Joyce","year":"2016","unstructured":"Joyce S, Gordon K, Brice G, Ostergaard P, Nagaraja R, Short J, et al. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome. Eur J Hum Genet. 2016;24:690\u20136.","journal-title":"Eur J Hum Genet"},{"key":"1123_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41431-020-00708-6","volume":"29","author":"C Lissewski","year":"2021","unstructured":"Lissewski C, Chune V, Pantaleoni F, De Luca A, Capri Y, Brinkmann J, et al. Variants of SOS2 are a rare cause of Noonan syndrome with particular predisposition for lymphatic complications. Eur J Hum Genet. 2021;29:51\u201360.","journal-title":"Eur J Hum Genet"},{"key":"1123_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MCD.0000000000000347","volume":"30","author":"ES Traub","year":"2021","unstructured":"Traub ES, Sheppard SE, Dori Y, Burns KD, Zackai EH, Ware SM, et al. Chromosome 4q28.3q32.3 duplication in a patient with lymphatic malformations, craniosynostosis, and dysmorphic features. Clin Dysmorphol. 2021;30:89\u201392.","journal-title":"Clin Dysmorphol"},{"key":"1123_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9085","volume":"6","author":"E Fotiou","year":"2015","unstructured":"Fotiou E, Martin-Almedina S, Simpson MA, Lin S, Gordon K, Brice G, et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015;6:8085.","journal-title":"Nat Commun"},{"key":"1123_CR18","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1007\/s00330-019-06112-z","volume":"29","author":"DM Biko","year":"2019","unstructured":"Biko DM, Smith CL, Otero HJ, Saul D, White AM, DeWitt A, et al. Intrahepatic dynamic contrast MR lymphangiography: initial experience with a new technique for the assessment of liver lymphatics. Eur Radio. 2019;29:5190\u20136.","journal-title":"Eur Radio"},{"key":"1123_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajhg.2020.11.013","volume":"108","author":"LG Biesecker","year":"2021","unstructured":"Biesecker LG, Adam MP, Alkuraya FS, Amemiya AR, Bamshad MJ, Beck AE, et al. A dyadic approach to the delineation of diagnostic entities in clinical genomics. Am J Hum Genet. 2021;108:8\u201315.","journal-title":"Am J Hum Genet."}],"updated-by":[{"DOI":"10.1038\/s41431-022-01130-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000}}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01123-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01123-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01123-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T23:05:04Z","timestamp":1662073504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01123-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01123-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41431-022-01130-w","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41431-022-01130-w","URL":"https:\/\/doi.org\/10.1038\/s41431-022-01130-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HH and The Children\u2019s Hospital of Philadelphia are equity holders in Nobias Therapeutics Inc., developing MEK inhibitor therapy for complex lymphatic anomalies. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Children\u2019s Hospital of Philadelphia Institutional Review Board approved a registry and biorepository study (PI YD). Informed consent was obtained from all participants as required by the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}